Renal transplantation in patients with HIV
- 1 October 2009
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 5 (10) , 582-589
- https://doi.org/10.1038/nrneph.2009.140
Abstract
The presence of HIV has historically been viewed as a contraindication to transplantation because of the risks associated with immunosuppression in patients who are already immunocompromised, the lack of long-term outcomes data to justify the use of a limited supply of donor organs, and the possibility of viral transmission to surgical staff. Frassetto and colleagues examine the issues surrounding kidney transplantation in patients with HIV and describe a range of strategies that optimize outcomes in these individuals. HIV infection has been a major global health problem for almost three decades. With the introduction of highly active antiretroviral therapy in 1996, and the advent of effective prophylaxis and management of opportunistic infections, AIDS mortality has decreased markedly. In developed countries, this once fatal infection is now being treated as a chronic condition. As a result, rates of morbidity and mortality from other medical conditions leading to end-stage liver, kidney and heart disease are steadily increasing in individuals with HIV. Presence of HIV infection used to be viewed as a contraindication to transplantation for multiple reasons: concerns for exacerbation of an already immunocompromised state by administration of additional immunosuppressants; the use of a limited supply of donor organs with unknown long-term outcomes; and, the risk of viral transmission to the surgical and medical staff. This Review examines open questions on kidney transplantation in patients infected with HIV-1 and clinical strategies that have resulted in good outcomes. It also describes the clinical concerns associated with the treatment of renal transplant recipients with HIV.Keywords
This publication has 83 references indexed in Scilit:
- The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical ImplicationsToxicologic Pathology, 2009
- Sodium, hypertension, and an explanation of the “lag phenomenon” in hemodialysis patientsHemodialysis International, 2008
- Impact of Immunosuppressive Regimen on Survival of Kidney Transplant Recipients With Hepatitis CTransplantation, 2008
- HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year OutcomesAmerican Journal of Transplantation, 2008
- Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART eraWorld Journal of Gastroenterology, 2008
- Survival during Renal Replacement Therapy among African Americans Infected with HIV Type 1 in Urban Baltimore, MarylandClinical Infectious Diseases, 2007
- Low Rates of Antiretroviral Therapy among HIV-Infected Patients with Chronic Kidney DiseaseClinical Infectious Diseases, 2007
- Outcome and Prognosis Factors in HIV-Infected Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2006
- The Immunosuppressant Rapamycin Represses Human Immunodeficiency Virus Type 1 ReplicationAntimicrobial Agents and Chemotherapy, 2002
- Associated Focal and Segmental Glomerulosclerosis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984